Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer
Curr Oncol
.
2009 Sep;16(5):3-8.
doi: 10.3747/co.v16i5.464.
Authors
F Kraeber-Bodéré
1
,
D M Goldenberg
,
J F Chatal
,
J Barbet
Affiliation
1
Nuclear Medicine Department, University Hospital, Nantes, France.
PMID:
19862356
PMCID:
PMC2768511
DOI:
10.3747/co.v16i5.464
No abstract available
Keywords:
Pretargeted radioimmunotherapy; calcitonin; medullary thyroid cancer.